Alpha-Lipoic Acid for Neuropathy: What the Evidence Actually Shows

Alpha-lipoic acid (ALA) is the single most studied supplement ingredient for peripheral neuropathy symptoms. Here is what the research supports, what it does not, and how to read a label honestly.

NU Nerve Review Editorial Team Updated May 7, 2026 9 min read
Alpha-lipoic acid supplement capsules with green botanicals under neon pink and blue lighting

What alpha-lipoic acid is

Alpha-lipoic acid is a compound your body makes in small amounts and uses inside mitochondria, the parts of a cell that generate energy. It is unusual among antioxidants because it dissolves in both water and fat, so it can act in more places in the body than most. In nerve research the interest is in oxidative stress: high blood sugar and poor microcirculation damage small nerve fibres over time, and ALA is studied as a way to reduce that stress.

What the studies show

The best-known work is the ALADIN and SYDNEY series of trials in diabetic peripheral neuropathy, plus the four-year NATHAN 1 trial. The consistent finding is a modest improvement in symptom scores — burning, prickling, numbness and pain — compared with placebo, at 600 mg per day. Intravenous ALA produced faster symptom change over 3 to 5 weeks; oral ALA needed months and showed smaller effects on nerve conduction than on how people felt.

The honest summary: ALA is one of the few nerve-health ingredients with repeated human trials behind it, the effect size is real but moderate, and it works best as part of blood-sugar and lifestyle management rather than instead of it.

Doses used in research

  • 600 mg/day oral — the standard dose across most trials.
  • 1,200–1,800 mg/day — tested, but no clear extra benefit and more nausea.
  • IV protocols — clinical settings only, not something a supplement replaces.

How long it takes

Expect to judge it over months, not days. Oral trials measured change at 3, 6 and 12 months. If a product promises overnight results, that promise is not coming from the ALA research.

Safety and interactions

At 600 mg/day ALA is generally well tolerated. The most common complaints are nausea, heartburn and a rash. Because it can lower blood glucose, anyone on insulin or oral diabetes medication should speak to their doctor first. ALA can also interact with thyroid medication and chemotherapy agents.

Where NU Nerve fits

NU Nerve is a liquid nerve support formula whose marketing lists alpha-lipoic acid alongside methylcobalamin (B12), benfotiamine and acetyl-L-carnitine. Our position is simple and unchanged: check the actual per-serving amount of ALA on the label you receive, and compare it with the 600 mg/day used in research. A formula that hides amounts inside a "proprietary blend" cannot be compared with the evidence at all.

Sources

Medical disclaimer: this article is general information, not medical advice. Supplements are not intended to diagnose, treat, cure or prevent any disease. Talk to your doctor before starting any supplement, especially if you are pregnant, nursing, diabetic or taking prescription medication.